CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lexaria Bioscience Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lexaria Bioscience Corp
100 - 740 MCCURDY ROAD
Phone: (250) 765-6424p:250 765-6424 KELOWNA, BC  V1X 2P7  Canada Ticker: LEXXLEXX
Business Summary
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20258/31/2024YesYes---

Industries
SIC Code Description
1000 Metal mining
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
6794 Patent owners and lessors

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Christopher A.Bunka 62 8/31/2024 10/26/2006
President, Director John M.Docherty 54 4/29/2016 4/15/2015
Chief Executive Officer RichardChristopher 8/31/2024 8/31/2024
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Kelowna Management Services Corp.
Lexaria (AU) Pty Ltd
Lexaria CanPharm Holding Corp.
9 additional Business Names available in full report.

General Information
Number of Employees: 7 (As of 8/31/2024)
Outstanding Shares: 19,484,179 (As of 4/24/2025)
Shareholders: 33
Stock Exchange: NASD
Federal Tax Id: 202000871
Fax Number: (604) 685-7602


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 13, 2025